Evidence map›Paper›PMID 38352179›Full record

ReviewBJR open2024

State of the art: radiomics and radiomics-related artificial intelligence on the road to clinical translation.

Shweta Majumder, Sharyn Katz, Despina Kontos, Leonid Roshkovan

Abstract readReview
In one paragraph

Review in BJR open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Imaging Immunotherapy.Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer · 2026
    Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Use of Radiomics in Characterizing Tumor Hypoxia.International journal of molecular sciences · 2025
    Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Shweta MajumderDepartment of Radiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, United States.
Sharyn KatzDepartment of Radiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, United States.ORCID https://orcid.org/0000-0001-9816-2291
Despina KontosDepartment of Radiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, United States.ORCID https://orcid.org/0000-0001-9031-5126
Leonid RoshkovanDepartment of Radiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, United States.ORCID https://orcid.org/0000-0002-8890-8835

Funding

Radiogenomic Biomarkers of Breast Cancer RecurrenceR01CA223816 · NCI · UNIVERSITY OF PENNSYLVANIA · PI CHODOSH, LEWIS A, KONTOS, DESPINA · 2018 to 2022
$3.1M
NCI NIH HHS R01 CA223816
6 · The paper itself

Abstract

Radiomics and artificial intelligence carry the promise of increased precision in oncologic imaging assessments due to the ability of harnessing thousands of occult digital imaging features embedded in conventional medical imaging data. While powerful, these technologies suffer from a number of sources of variability that currently impede clinical translation. In order to overcome this impediment, there is a need to control for these sources of variability through harmonization of imaging data acquisition across institutions, construction of standardized imaging protocols that maximize the acquisition of these features, harmonization of post-processing techniques, and big data resources to properly power studies for hypothesis testing. For this to be accomplished, it will be critical to have multidisciplinary and multi-institutional collaboration.

Indexed as

artificial intelligencedeep learningmachine learningoncologic imagingradiomics

Identifiers

PMID38352179
PMCPMC10860524

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.